FoxO proteins: Cunning concepts and considerations for the cardiovascular system

Clinical Science

Volumn 116, Issue 3, 2009, Pages 191-203

  Maiese, Kenneth ^a,b   Chong, Zhao Zhong ^a   Shang, Yan Chen ^a   Hou, Jinling ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cancer; Cardiovascular disease; Diabetes; Forkhead box (Fox); Immune system; Oxidative stress; Stem cell

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; BETA CATENIN; BIM PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ERYTHROPOIETIN; GAMMA INTERFERON; GELATINASE B; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; I KAPPA B KINASE; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN 14 3 3; PROTEIN KINASE B; PROTEIN P27; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SOMATOMEDIN BINDING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR DAF 16; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; UNINDEXED DRUG; WNT1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR;

AGING; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CARDIOVASCULAR DISEASE; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS; DRUG SENSITIVITY; HEART DEVELOPMENT; HUMAN; HYPERTENSION; IMMUNOREGULATION; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STROKE; AUTOIMMUNE DISEASE; CARDIOVASCULAR SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; AUTOIMMUNE DISEASES; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; STROKE;

EID: 60549094617     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080113     Document Type: Review

References (121)

1. Maiese, K. (2008) Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus. Biomed. Pharmacother. 62, 218-232
2. Weigel, D., Jurgens, G., Kuttner, F., Seifert, E. and Jackle, H. (1989) The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57, 645-658
3. Kaestner, K. H., Knochel, W. and Martinez, D. E. (2000) Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14, 142-146
4. Clark, K. L., Halay, E. D., Lai, E. and Burley, S. K. (1993) Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364, 412-420
5. Larson, E. T., Eilers, B., Menon, S. et al. (2007) A winged-helix protein from Sulfolobus turreted icosahedral virus points toward stabilizing disulfide bonds in the intracellular proteins of a hyperthermophilic virus. Virology 368, 249-261
6. 15N relaxation NMR. Biochemistry 37, 6179-6187
7. Maiese, K., Chong, Z. Z. and Shang, Y. C. (2008) OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol. Med. 14, 219-227
8. Wijchers, P. J., Burbach, J. P. and Smidt, M. P. (2006) In control of biology: of mice, men and Foxes. Biochem. J. 397, 233-246
9. Lin, K., Dorman, J. B., Rodan, A. and Kenyon, C. (1997) Daf-16: an HNF-3/ forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319-1322
10. Ogg, S., Paradis, S., Gottlieb, S. et al. (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994-999
11. Maiese, K., Chong, Z. Z. and Shang, Y. C. (2007) 'Sly as a FOXO': new paths with Forkhead signaling in the brain. Curr. Neurovasc. Res. 4, 295-302
12. Furuyama, T., Nakazawa, T., Nakano, I. and Mori, N. (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349, 629-634
13. Biggs, III, W. H., Cavenee, W. K. and Arden, K. C. (2001) Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome 12, 416-425
14. Hoekman, M. F., Jacobs, F. M., Smidt, M. P. and Burbach, J. P. (2006) Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr. Patterns 6, 134-140
15. Jagani, Z., Singh, A. and Khosravi-Far, R. (2008) FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis. Biochim. Biophys. Acta 1785, 63-84
16. Myatt, S. S. and Lam, E. W. (2007) The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer. 7, 847-859
17. van der Horst, A. and Burgering, B. M. (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell. Biol. 8, 440-450
18. Chong, Z. Z., Kang, J. Q. and Maiese, K. (2002) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106, 2973-2979
19. Chong, Z. Z., Li, F. and Maiese, K. (2005) Erythropoietin requires NF-κB and its nuclear translocation to prevent early and late apoptotic neuronal injury during β-amyloid toxicity. Curr. Neurovasc. Res. 2, 387-399
20. Chong, Z. Z., Li, F. and Maiese, K. (2007) Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell. Signalling 19, 1150-1162
21. Kim, K. H., Oudit, G. Y. and Backx, P. H. (2008) Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. J. Pharmacol. Exp. Ther. 324, 160-169
22. Kops, G. J., de Ruiter, N. D., De Vries-Smits, A. M., Powell, D. R., Bos, J. L. and Burgering, B. M. (1999) Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398, 630-634
23. Tang, E. D., Nunez, G., Barr, F. G. and Guan, K. L. (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274, 16741-16746
24. Biggs, III, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K. and Arden, K. C. (1999) Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. U.S.A. 96, 7421-7426
25. Chong, Z. Z. and Maiese, K. (2007) Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-13-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br. J. Pharmacol. 150, 839-850
26. Maiese, K., Li, F. and Chong, Z. Z. (2005) New avenues of exploration for erythropoietin. JAMA, J. Am. Med. Assoc. 293, 90-95
27. L and caspase 1, 3, and 9. Exp. Cell Res. 296, 196-207
28. Chong, Z. Z. and Maiese, K. (2007) The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol. Histopathol. 22, 1251-1267
29. L, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J. Cereb. Blood Flow Metab. 23, 320-330
30. Chong, Z. Z., Kang, J. Q. and Maiese, K. (2003) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br. J. Pharmacol. 138, 1107-1118
31. Chong, Z. Z., Kang, J. Q. and Maiese, K. (2004) Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. Antioxid. Redox Signaling 6, 277-287
32. Chong, Z. Z., Li, F. and Maiese, K. (2006) Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and β-catenin during oxidative stress. Curr. Neurovasc. Res. 3, 107-117
33. + precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J. Cereb. Blood Flow Metab. 24, 728-743
34. Obexer, P., Geiger, K., Ambros, P. F., Meister, B. and Ausserlechner, M. J. (2007) FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ. 14, 534-547
35. Plas, D. R. and Thompson, C. B. (2003) Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J. Biol. Chem. 278, 12361-12366
36. Lehtinen, M. K., Yuan, Z., Boag, P. R. et al. (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125, 987-1001
37. Song, J. J. and Lee, Y. J. (2008) Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily. Cell. Signalling 20, 892-906
38. Chong, Z. Z., Li, F. and Maiese, K. (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog. Neurobiol. 75, 207-246
39. Maiese, K. (2008) Diabetic stress: new triumphs and challenges to maintain vascular longevity. Expert Rev. Cardiovasc. Ther. 6, 281-284
40. Maiese, K. and Chong, Z. Z. (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci. 24, 228-232
41. Slomka, M., Zieminska, E. and Lazarewicz, J. (2008) Nicotinamide and 1-methylnicotinamide reduce homocysteine neurotoxicity in primary cultures of rat cerebellar granule cells. Acta Neurobiol. Exp. 68, 1-9
42. Maiese, K., Chong, Z. Z., Hou, J. and Shang, Y. C. (2008) Erythropoietin and oxidative stress. Curr. Neurovasc. Res. 5, 125-142
43. Nakamura, T. and Sakamoto, K. (2007) Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. Mol. Cell. Endocrinol. 281, 47-55
44. Barthelemy, C., Henderson, C. E. and Pettmann, B. (2004) Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. BMC Neurosci. 5, 48
45. You, H., Yamamoto, K. and Mak, T. W. (2006) Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc. Natl. Acad. Sci. U.S.A. 103, 9051-9056
46. Won, C. K., Ji, H. H. and Koh, P. O. (2006) Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci. Lett. 398, 39-43
47. Caporali, A., Sala-Newby, G. B., Meloni, M. et al. (2008) Identification of the prosurvival activity of nerve growth factor on cardiac myocytes. Cell Death Differ. 15, 299-311
48. Puig, O. and Tjian, R. (2005) Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19, 2435-2446
49. Tothova, Z., Kollipara, R., Huntly, B. J. et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325-339
50. Ferrara, N., Rinaldi, B., Corbi, G. et al. (2007) Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res. 11, 139-150
51. Li, F., Chong, Z. Z. and Maiese, K. (2006) Winding through the WNT pathway during cellular development and demise. Histol. Histopathol. 21, 103-124
52. Maiese, K., Li, F., Chong, Z. Z. and Shang, Y. C. (2008) The Wnt signaling pathway: aging gracefully as a protectionist? Pharmacol. Ther. 118, 58-81
53. Smith, W. W., Norton, D. D., Gorospe, M. et al. (2005) Phosphorylation of p66Shc and forkhead proteins mediates Aβ toxicity. J. Cell Biol. 169, 331-339
54. Hoogeboom, D., Essers, M. A., Polderman, P. E., Voets, E., Smits, L. M. and Burgering, B. M. (2008) Interaction of FOXO with β-catenin inhibits β-catenin/t cell factor activity. J. Biol. Chem. 283, 9224-9230
55. Naito, A. T., Akazawa, H., Takano, H. et al. (2005) Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ. Res. 97, 144-151
56. Maiese, K., Chong, Z. Z. and Shang, Y. C. (2008) Raves and risks for erythropoietin. Cytokine Growth Factor Rev. 19, 145-155
57. Hosaka, T., Biggs, III, W. H., Tieu, D. et al. (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U.S.A. 101, 2975-2980
58. Furuyama, T., Kitayama, K., Shimoda, Y. et al. (2004) Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279, 34741-34749
59. Evans-Anderson, H. J., Alfieri, C. M. and Yutzey, K. E. (2008) Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ. Res. 102, 686-694
60. Li, H. H., Willis, M. S., Lockyer, P. et al. (2007) Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J. Clin. Invest. 117, 3211-3223
61. Abid, M. R., Yano, K., Guo, S. et al. (2005) Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J. Biol. Chem. 280, 29864-29873
62. Liu, Z. P., Wang, Z., Yanagisawa, H. and Olson, E. N. (2005) Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell 9, 261-270
63. Li, H., Liang, J., Castrillon, D. H., DePinho, R. A., Olson, E. N. and Liu, Z. P. (2007) FoxO4 regulates tumor necrosis factor α-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 27, 2676-2686
64. Goettsch, W., Gryczka, C., Korff, T. et al. (2008) Flow-dependent regulation of angiopoietin-2. J. Cell. Physiol. 214, 491-503
65. 1-adrenergic agonists. Endocrinology 146, 4370-4376
66. Sedding, D. G., Seay, U., Fink, L. et al. (2003) Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells. Circulation 108, 616-622
67. Hannenhalli, S., Putt, M. E., Gilmore, J. M. et al. (2006) Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 114, 1269-1276
68. Maiese, K., Chong, Z. Z., Li, F. and Shang, Y. C. (2008) Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog. Neurobiol. 85, 194-213
69. Kikuchi, S., Nagai, T., Kunitama, M., Kirito, K., Ozawa, K. and Komatsu, N. (2007) Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci. 98, 1949-1958
70. Nowak, K., Killmer, K., Gessner, C. and Lutz, W. (2007) E2F-1 regulates expression of FOXO1 and FOXO3a. Biochim. Biophys. Acta 1769, 244-252
71. Brunet, A., Sweeney, L. B., Sturgill, J. F. et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015
72. Paik, J. H., Kollipara, R., Chu, G. et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323
73. 2-terminal kinase and Akt. Cancer Res. 66, 212-220
74. Eddy, S. F., Kane, S. E. and Sonenshein, G. E. (2007) Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res. 67, 9018-9023
75. Li, Y., Wang, Z., Kong, D. et al. (2007) Regulation of FOXO3a /β-catenin/GSK-3β signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J. Biol. Chem. 282, 21542-21550
76. Delpuech, O., Griffiths, B., East, P. et al. (2007) Induction of Mxi1-SRα by FOXO3a contributes to repression of Myc-dependent gene expression. Mol. Cell. Biol. 27, 4917-4930
77. Ticchioni, M., Essafi, M., Jeandel, P. Y. et al. (2007) Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 26, 7081-7091
78. Yang, L., Xie, S., Jamaluddin, M. S. et al. (2005) Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. J. Biol. Chem. 280, 33558-33565
79. Arimoto-Ishida, E., Ohmichi, M., Mabuchi, S. et al. (2004) Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin. Endocrinology 145, 2014-2022
80. Sauvageot, C. M., Kesari, S. and Stiles, C. D. (2007) Molecular pathogenesis of adult brain tumors and the role of stem cells. Neurol. Clin. 25, 891-924
81. Miyamoto, K., Araki, K. Y., Naka, K. et al. (2007) Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cells 1, 101-112
82. Arcasoy, M. O. (2008) The non-haematopoietic biological effects of erythropoietin. Br. J. Haematol. 141, 14-31
83. Cariou, A., Claessens, Y. E., Pene, F. et al. (2008) Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 76, 397-404
84. Chong, Z. Z., Shang, Y. C. and Maiese, K. (2007) Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr. Neurovasc. Res. 4, 194-204
85. Bakker, W. J., van Dijk, T. B., Parren-van Amelsvoort, M. et al. (2007) Differential regulation of Foxo3a target genes in erythropoiesis. Mol. Cell. Biol. 27, 3839-3854
86. Furukawa-Hibi, Y., Yoshida-Araki, K., Ohta, T., Ikeda, K. and Motoyama, N. (2002) FOXO forkhead transcription factors induce G-M checkpoint in response to oxidative stress. J. Biol. Chem. 277, 26729-26732
87. Liu, L., Rajareddy, S., Reddy, P. et al. (2007) Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development 134, 199-209
88. Watkins, W. J., Umbers, A. J., Woad, K. J. et al. (2006) Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil. Steril. 86, 1518-1521
89. Maiese, K., Chong, Z. Z. and Shang, Y. C. (2007) Mechanistic insights into diabetes mellitus and oxidative stress. Curr. Med. Chem. 14, 1729-1738
90. Maiese, K., Morhan, S. D. and Chong, Z. Z. (2007) Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr. Neurovasc. Res. 4, 63-71
91. Donahoe, S. M., Stewart, G. C., McCabe, C. H. et al. (2007) Diabetes and mortality following acute coronary syndromes. JAMA, J. Am. Med. Assoc. 298, 765-775
92. Guo, S., Rena, G., Cichy, S., He, X., Cohen, P. and Unterman, T. (1999) Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274, 17184-17192
93. Nakae, J., Park, B. C. and Accili, D. (1999) Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J. Biol. Chem. 274, 15982-15985
94. Kim, J. R., Jung, H. S., Bae, S. W. et al. (2006) Polymorphisms in FOXO gene family and association analysis with BMI. Obesity 14, 188-193
95. Kuningas, M., Magi, R., Westendorp, R. G., Slagboom, P. E., Remm, M. and van Heemst, D. (2007) Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age. Eur. J. Hum. Genet. 15, 294-301
96. Marchetti, V., Menghini, R., Rizza, S. et al. (2006) Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 55, 2231-2237
97. Fallarino, F., Bianchi, R., Orabona, C. et al. (2004) CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J. Exp. Med. 200, 1051-1062
98. 1-mediated mesangial cell dysfunction: A novel mechanism related to diabetic kidney disease. J. Am. Soc. Nephrol. 17, 3325-3335
99. Nakae, J., Cao, Y., Oki, M. et al. (2008) Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes 57, 563-576
100. Furuyama, T., Yamashita, H., Kitayama, K., Higami, Y., Shimokawa, I. and Mori, N. (2002) Effects of aging and caloric restriction on the gene expression of Foxo1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles. Microsc. Res. Tech. 59, 331-334
101. Ni, Y. G., Wang, N., Cao, D. J. et al. (2007) FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc. Natl. Acad. Sci. U.S.A. 104, 20517-20522
102. Kamei, Y., Miura, S., Suzuki, M. et al. (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279, 41114-41123
103. + precursor nicotinamide. Curr. Med. Chem. 13, 883-895
104. Nemoto, S., Fergusson, M. M. and Finkel, T. (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306, 2105-2108
105. Motta, M. C., Divecha, N., Lemieux, M. et al. (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551-563
106. Kyoung Kim, H., Kyoung Kim, Y., Song, I. H. et al. (2005) Down-regulation of a forkhead transcription factor, FOXO3a, accelerates cellular senescence in human dermal fibroblasts. J. Gerontol. A. Biol. Sci. Med. Sci. 60, 4-9
107. Alcendor, R. R., Gao, S., Zhai, P. et al. (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512-1521
108. Li, M., Chiu, J. F., Mossman, B. T. and Fukagawa, N. K. (2006) Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats. J. Biol. Chem. 281, 40429-40439
109. Miyauchi, H., Minamino, T., Tateno, K., Kunieda, T., Toko, H. and Komuro, I. (2004) Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 23, 212-220
110. Kang, J. Q., Chong, Z. Z. and Maiese, K. (2003) Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol. Pharmacol. 64, 557-569
111. Chong, Z. Z., Kang, J., Li, F. and Maiese, K. (2005) mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. Curr. Neurovasc. Res. 2, 197-211
112. Chong, Z. Z., Li, F. and Maiese, K. (2007) The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3β and nuclear factor-κB to foster endogenous microglial cell protection. Int. J. Mol. Med. 19, 263-272
113. Li, F., Chong, Z. Z. and Maiese, K. (2006) Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3β, β-catenin, and nuclear factor-κB. Curr. Neurovasc. Res. 3, 187-201
114. Ludikhuize, J., de Launay, D., Groot, D. et al. (2007) Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum. 56, 2180-2191
115. Kuo, C. C. and Lin, S. C. (2007) Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Mol. Med. 13, 561-566
116. Lin, L., Hron, J. D. and Peng, S. L. (2004) Regulation of NF-κB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203-213
117. Jonsson, H., Allen, P. and Peng, S. L. (2005) Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat. Med. 11, 666-671
118. Sela, U., Dayan, M., Hershkoviz, R., Cahalon, L., Lider, O. and Mozes, E. (2006) The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses. Eur. J. Immunol. 36, 2971-2980
119. Hur, E. M., Youssef, S., Haws, M. E., Zhang, S. Y., Sobel, R. A. and Steinman, L. (2007) Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8, 74-83
120. Gomez-Gutierrez, J. G., Souza, V., Hao, H. Y. et al. (2006) Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells. Cancer Biol. Ther. 5, 875-883
121. Zethelius, B., Berglund, L., Sundstrom, J. et al. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N. Engl. J. Med. 358, 2107-2116